An assessment of the clinical equivalence of valproate chrono and extended release divalproex formulations
<b>Objective:</b> No guideline currently exists to choose the clinically equivalent dose of divalproex extended release (ER) formulation while switching over from valproate chrono formulation. To address this issue, we evaluated the serum valproate concentration following switch over fr...
Main Authors: | Rajesh B, Ashalatha R, Sarma Sankara, Radhakrishnan K |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2007-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2007;volume=10;issue=3;spage=169;epage=174;aulast=Rajesh |
Similar Items
-
Valproate, divalproex, valpromide: Are the differences in indications justified?
by: Clément Delage, et al.
Published: (2023-02-01) -
Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials
by: Chen Qi Zhang, et al.
Published: (2022-04-01) -
TREATMENT OF EPILEPSY IN CHILDREN: SPECIAL PHARMACEUTICAL FORMS
by: Е. D. Belousova
Published: (2016-08-01) -
Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
by: Davis Erica A. K. PharmD, BCPS, BCPP
Published: (2023-06-01) -
Valproate-induced hypothyroidism in schizoaffective disorder
by: J. Facucho-Oliveira, et al.
Published: (2022-06-01)